Literature DB >> 6190410

Pancreatic acini in short-term culture: regulation by EGF, carbachol, insulin, and corticosterone.

C D Logsdon, J A Williams.   

Abstract

To define the hormonal regulation of the exocrine pancreas, acini were maintained for 24 h in suspension culture under various conditions and then examined morphologically and tested for their ability to synthesize and secrete protein. Acini cultured in the presence of 20% fetal calf serum (control conditions) retained their differentiated morphology as judged by light and electron microscopy. Under control conditions, stimulation with either cholecystokinin octapeptide (CCK8) or carbachol increased the release of amylase in a dose-dependent manner with a maximal threefold increase occurring at 200 pM CCK8 or 6 microM carbachol. Without inclusion of other factors in the medium during the culture period, the rate of protein synthesis measured in cultured acini was one-third the rate measured in freshly prepared acini. Inclusion of epidermal growth factor (EGF) (2 nM), carbachol (1 microM), or insulin (1 microM) during the culture period led to increases, whereas corticosterone (1 microM) led to decreases in functional parameters. Greatest effects were seen with a combination of EGF, carbachol, and insulin. This combination of factors led to a 160% increase over control in CCK8-stimulated amylase release and a 180% increase in [3H]leucine incorporation. These results indicate that isolated pancreatic acini can be maintained for up to 24 h and that EGF, carbachol, insulin, and corticosterone can regulate the long-term function of this tissue.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6190410     DOI: 10.1152/ajpgi.1983.244.6.G675

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  14 in total

1.  Zymogen granule fragility as a parameter for ascertaining the functional state of pancreatic acinar cells in vitro.

Authors:  S Kurup; R R Bhonde
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-06       Impact factor: 2.416

2.  Two subclasses of EGF receptors in the human pancreatic cancer cell lines CAPAN-1 and MIA PaCa-2.

Authors:  P Oustry; A Estival; L Pradayrol; N Vaysse; F Clémente
Journal:  Int J Pancreatol       Date:  1990-03

3.  HPAC, a new human glucocorticoid-sensitive pancreatic ductal adenocarcinoma cell line.

Authors:  W R Gower; R M Risch; C V Godellas; P J Fabri
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-03       Impact factor: 2.416

4.  Using pancreas tissue slices for in situ studies of islet of Langerhans and acinar cell biology.

Authors:  Anja Marciniak; Christian M Cohrs; Vasiliki Tsata; Julie A Chouinard; Claudia Selck; Julia Stertmann; Saskia Reichelt; Tobias Rose; Florian Ehehalt; Jürgen Weitz; Michele Solimena; Marjan Slak Rupnik; Stephan Speier
Journal:  Nat Protoc       Date:  2014-11-13       Impact factor: 13.491

5.  Alterations in EGF binding to acini during pancreatic regeneration in the rat.

Authors:  J S Brockenbrough; G C Weir; M Korc
Journal:  Int J Pancreatol       Date:  1988-12

Review 6.  The islet-acinar axis of the pancreas.

Authors:  J von Schönfeld; H Goebell; M K Müller
Journal:  Int J Pancreatol       Date:  1994 Oct-Dec

7.  Distribution, release, and secretory activity of epidermal growth factor in the pancreas.

Authors:  J Jaworek; S J Konturek
Journal:  Int J Pancreatol       Date:  1990-04

8.  c-Jun/AP-1 is required for CCK-induced pancreatic acinar cell dedifferentiation and DNA synthesis in vitro.

Authors:  Lili Guo; Maria Dolors Sans; Yanan Hou; Stephen A Ernst; John A Williams
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-29       Impact factor: 4.052

9.  Primary cultures of rat pancreatic acinar cells in serum-free medium.

Authors:  P M Brannon; B M Orrison; N Kretchmer
Journal:  In Vitro Cell Dev Biol       Date:  1985-01

10.  Intracellular Ca2+ and phorbol esters synergistically inhibit internalization of epidermal growth factor in pancreatic acini.

Authors:  C D Logsdon; J A Williams
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.